2021年安徽省居民中医药健康文化知识普及情况及影响因素分析

目的 分析2021年安徽省居民中医药健康文化知识普及情况及其影响因素,为制定有针对性的中医科普政策提供科学依据。方法 采用多阶段分层整群随机抽样的方法,抽取安徽省2913名15~69岁常住居民进行入户问卷调查。结果 回收有效问卷2909份,有效率为99.86%。2021年安徽省居民中医药健康文化知识普及率为88.14%。不同人群中医药知识普及程度存在差异。以女性、农村和不识字/少识字人群为对照,男性(OR=1.320,95%CI=1.001~1.740)、城市(OR=1.623,95%CI=1.246~2.114)、大专/本科及以上(OR=18.965,95%CI=8.531~42.161)居民的中医药健康文化知识普及水平更高。性别、城乡分布和文化程度是居民中医药健康文化知识普及的独立影响因素。结论 应根据群体特征制定有针对性的中医健康教育与健康促进策略,加强重点地区、重点人群的中医药健康文化普及工作,同时注重完善中医药科普的内容与传播途径,以提高中医药健康素养水平,发扬中医的重要作用。

独活寄生通痹汤联合玻璃酸钠关节腔注射治疗膝关节骨性关节炎疗效观察

目的:观察中药独活寄生通痹汤配合玻璃酸钠关节腔内注射治疗膝关节骨性关节炎的临床疗效。方法:将60例患者随机分为两组各30例,治疗组给予独活寄生通痹汤口服,配合玻璃酸钠关节腔内注射,对照组仅给予玻璃酸钠关节腔内注射。两组均连续治疗4周。观察两组疗效。结果:治疗组治愈15例,有效12例,无效3例,总有效率为90.0%;对照组治愈10例,有效10例,无效10例,总有效率为66.7%。治疗组临床疗效显著高于对照组(P﹤0.05),治疗组在改善VAS积分、KSS评分方面效果优于对照组,两组间差异有统计学意义(P﹤0.05或P﹤0.01)。结论:独活寄生通痹汤联合玻璃酸钠关节腔内注射治疗膝关节骨性关节炎疗效确切,优于单纯使用玻璃酸钠关节腔内注射。

安徽省健康教育人员培训需求状况分析

目的了解全省市县级健康教育人员的培训需求,为健康教育能力建设提供科学依据。方法使用自制问卷对市、县两级健康教育人员开展培训需求的调查,采用EpiData软件进行数据双录入,应用SPSS 21.0软件统计描述和分析。结果本次调查共回收有效问卷296份,调查对象平均年龄(41.02±8.91)岁;高级职称占9.8%、中级职称占39.5%;从业年限的中位数是3(1-10)年。培训需求依次为场所健康教育(占54.1%)、其他专题健康教育(占53.0%)、健康教育理论(占50.6%)、健康教育实用技能(占40.4%)、疾病健康教育(占37.1%)。市级健康教育人员对场所健康教育的培训需求高于县(区)级(χ^(2)=8.636,P=0.003),而疾病健康教育及其他专题健康教育方面则低于县(区)级(χ^(2)=9.405,16.90,P=0.002,<0.001);高级职称者对场所健康教育和其他专题健康教育低于其他调查对象(χ^(2)=11.060,18.543,P=0.011,<0.001);从业11年及以上的调查对象对健康教育实用技能的需求高于其他人群(χ^(2)=8.507,P=0.014)。培训方式主要是专家讲座(占86.5%)和现场参观(占81.8%)。75.7%的调查对象认为每次培训班应控制在3~5 d。结论不同调查对象对健康教育培训内容需求不同,应根据健康教育的需求开展针对性地培训工作。

Effect of Jiuwei Zhuhuang Powder on Cough Resolution in Children with Upper Respiratory Tract Infections:A Multicenter Randomized Controlled Trial

Objective:To assess the effectiveness of Jiuwei Zhuhuang Powder(JWZH),a Tibetan patent medicine in treating upper respiratory tract infection(URTI)associated cough in children.Methods:The study was a multicenter,randomized,open-label,controlled trial.A total of 142 children aged 2 to 14 years old,with URTIassociated cough within 48 h of onset,were randomly assigned to two groups at a 1:1 ratio by computer-generated randomization sequence.Children were treated with JWZH(1 to 1.5 g,twice to thrice daily)in the treatment group or conventional treatment(Pediatric Paracetamol,Artificial Cow-bezoar and Chlorphenamine Maleate Granules,0.25 to 1 g,thrice daily)in the control group for 5 days.The primary endpoints were the time to cough resolution and 4-day cough resolution rate.The secondary endpoints were the daily improvement in symptom scores and cough resolution rate during the study period.Results:A total of 138 children were included in the intention-to-treat analysis,with 71 cases in the treatment group and 67 cases in the control group.Compared with the conventional treatment,the children receiving JWZH had a shorter time to cough resolution[hazard ratio,2.10;95%confidence interval(CI),1.29-3.40;P=0.003].The median time to cough resolution for children receiving JWZH was shorter than that of the conventional treatment(2 days vs.3 days;P<0.001).The 4-day cough resolution rate in the JWZH group was higher than that of the control group(94.4%vs.74.6%;risk difference:19.8%,95%CI:8.1%-31.5%;relative risk:1.265,95%CI:1.088-1.470;P=0.001).There were no statistically significant differences in the improvement of other symptoms caused by URTI(P>0.05).Adverse events was reported in 5.6%(4/71)and 4.5%(3/67)in participants of JWZH and PPACCM groups(P>0.05),respectively,which were all mild and resolved without treatment.Conclusion:JWZH seemed to be a safe and effective therapy for URTI-associated cough in children.(Trial registration No.Chi CTR2000039421)